Zobrazeno 1 - 10
of 418
pro vyhledávání: '"Jabłecka, A."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Therapeutics and Clinical Risk Management, Vol Volume 15, Pp 1111-1119 (2019)
Katarzyna Korzeniowska,1 Artur Cieślewicz,1 Ewa Chmara,1 Anna Jabłecka,1 Mariola Pawlaczyk2 1Department of Clinical Pharmacology, Poznan University of Medical Sciences, Poznań 61-848, Poland; 2Department of Geriatric Medicine and Gerontology, Pozn
Externí odkaz:
https://doaj.org/article/5dcf1a71e1a54889b3713d17d29f9e79
Publikováno v:
Therapeutics and Clinical Risk Management, Vol Volume 15, Pp 1095-1110 (2019)
Katarzyna Korzeniowska, Jerzy Jankowski, Artur Cieślewicz, Anna Jabłecka Department of Clinical Pharmacology, Poznan University of Medical Sciences, Poznan 61-848, PolandCorrespondence: Artur CieślewiczDepartment of Clinical Pharmacology, Poznan U
Externí odkaz:
https://doaj.org/article/f80b7307cee940139e2c39ff4c6ac18d
Autor:
Synowiec, Zuzanna, Sobańska, Katarzyna, Synowiec, Tomasz, Teżyk, Artur, Tomczak, Piotr, Jabłecka, Anna
Publikováno v:
In Clinical Genitourinary Cancer August 2022 20(4):390-390
Publikováno v:
Medical Research Journal (2451-2591); 2024, Vol. 9 Issue 1, p58-64, 7p
Publikováno v:
In Pharmacological Reports October 2016 68(5):1015-1019
Autor:
Artur Cieślewicz, Magdalena Dudek, Iwona Krela-Kaźmierczak, Anna Jabłecka, Maciej Lesiak, Katarzyna Korzeniowska
Publikováno v:
Vaccines, Vol 9, Iss 6, p 576 (2021)
The COVID-19 pandemic has caused more than 3 million deaths worldwide. Recently developed genetically engineered vaccines are the most critical solution for controlling the pandemic. Clinical trials on a large number of participants confirmed their s
Externí odkaz:
https://doaj.org/article/69f8e84481c84ac7a61933fff5c1a9ce
Publikováno v:
In Pharmacological Reports December 2015 67(6):1098-1102
Autor:
Agnieszka Skotnicka, Anna Jabłecka
Publikováno v:
Folia Cardiologica. 17:20-26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7179c7235692e1ccd221a596d9f93c3
https://doi.org/10.5603/fc.2022.0004
https://doi.org/10.5603/fc.2022.0004
Background. Psychiatric patients are an interesting group due to the risk of mental exacerbation during the course of COVID-19. Most patients with severe mental disorders require long-term care in specialized centers such as psychiatric hospitals and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee095c078030472bb5e7cc11a80495cb
https://doi.org/10.21203/rs.3.rs-2642434/v1
https://doi.org/10.21203/rs.3.rs-2642434/v1
